Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M63.7Revenue (TTM) $M5.4Net Margin (%)2,135Altman Z-Score12.0
Enterprise Value $M-72.3EPS (TTM) $1.8Operating Margin %-124.4Piotroski F-Score6
P/E(ttm)0.5Beneish M-Score-6.3Pre-tax Margin (%)2,136Higher ROA y-yY
Price/Book0.510-y EBITDA Growth Rate %--Quick Ratio37.0Cash flow > EarningsY
Price/Sales11.25-y EBITDA Growth Rate %-24.7Current Ratio37.0Lower Leverage y-yY
Price/Free Cash Flow0.5y-y EBITDA Growth Rate %--ROA % (ttm)252Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)273Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M68.8ROIC % (ttm)-785.0Gross Margin Increase y-yN

Gurus Latest Trades with PIP

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

PIP is held by these investors:

PIP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PRESCOTT GROUP CAPITAL MANAGEM10% Owner 2016-12-09Sell1,354,632$3.26-71.47view
RICHMAN ERIC IDirector 2016-04-13Sell329,354$2.2-57.73view
RICHMAN ERIC IDirector 2016-04-08Sell11,767$2.2-57.73view
St Peter StevenDirector 2015-03-19Buy25,000$1.65-43.64view
CHANG LINDA LSVP, CFO & Secretary 2015-01-07Sell29,600$2.1-55.71view
PRESCOTT GROUP CAPITAL MANAGEM10% Owner 2014-09-22Buy15,000$1.55-40view
Runge Jeffrey W.Director 2011-12-12Buy20,000$1.3-28.46view
FUERST THOMAS RICHARDSVP, Chief Scientific Officer 2011-11-22Buy5,000$1.27-26.77view
CHANG LINDA LSVP & CFO 2011-11-16Buy10,000$1.38-32.61view
SAYARE MITCHELDirector 2011-08-18Buy5,000$2.17-57.14view

Quarterly/Annual Reports about PIP:

News about PIP:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
PharmAthene Inc (PIP) CEO Eric I Richman buys 10,000 Shares Jun 21 2010 
Guru Activities for Today’s Price % Losers: PharmAthene Inc. , Authentidate Holding Corp., Kroger Dec 08 2009 

More From Other Websites
Pepsico CFO: Great business in Mexico Feb 15 2017
Pepsico CFO: We have terrific momentum Feb 15 2017
Biotech Premarket Movers: PharmAthene, Earth Science Tech, Pulmatrix Feb 07 2017
Rite Aid, Supervalu Slump into Monday’s 52-Week Low Club Feb 06 2017
Altimmune to Present at the BIO CEO & Investor Conference Feb 06 2017
PHARMATHENE, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 01 2017
[$$] Gormley's Take: As IPO Market Tightens, Biotechs Find Another Route to Public Listing Feb 01 2017
PharmAthene and Altimmune to Merge in All-Stock Deal Jan 23 2017
ETFs with exposure to PharmAthene, Inc. : January 20, 2017 Jan 20 2017
Blog Coverage PharmAthene and Altimmune Announced a Merger; Set to Establish Immunotherapeutic... Jan 20 2017
Two of region's anthrax-fighting companies announce merger Jan 20 2017
PHARMATHENE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors... Jan 19 2017
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious... Jan 19 2017
ETFs with exposure to PharmAthene, Inc. : January 9, 2017 Jan 09 2017
ETFs with exposure to PharmAthene, Inc. : December 29, 2016 Dec 29 2016
ETFs with exposure to PharmAthene, Inc. : December 16, 2016 Dec 16 2016
ETFs with exposure to PharmAthene, Inc. : December 5, 2016 Dec 05 2016
PharmAthene Declares $2.91 Special Cash Dividend on Common Stock Nov 17 2016
PharmAthene Receives Final Payment from SIGA of $83.9 Million Nov 16 2016
PHARMATHENE, INC Financials Nov 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)